[1] Fan J, Yang J, Qiao W, et al. LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma[J]. Oncol Lett, 2020, 19(1):317-322.
[2] Jiang Y, Tang Y, Wang S, et al. PRRX1-induced epithelial-to-mesenchymal transition in salivary adenoid cystic carcinoma activates the metabolic reprogramming of free fatty acids to promote invasion and metastasis[J]. Cell Prolif, 2020, 53(1):e12705.
[3] Qiao Z, Zou Y, Zhao H. MicroRNA-140-5p inhibits salivary adenoid cystic carcinoma progression and metastasis via targeting survivin[J]. Cancer Cell Int, 2019, 19(1): 301-312.
[4] Xia Y, Li B, Gao N, et al. Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis[J]. Oncol Lett, 2014, 8(4): 1670-1674.
[5] Hu XM, Lin T, Huang XY, et al. ID1 contributes to cell growth invasion and migration in salivary adenoid cystic carcinoma[J]. Mol Med Rep, 2017, 16(6): 8907-8915.
[6] Liang Y, Ye J, Jiao J, et al. Down-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway[J]. Am J Transl Res, 2017, 9(3): 1101-1113.
[7] Qin SL, Zhou Y, Hu W, et al. Bioinformatics analysis and functional analysis of bladder cancer gene microarray[J]. Acta Anatomica Sinica, 2019, 50(3): 310-316. (in Chinese)
秦松林,周洋,胡威,等.膀胱癌基因芯片生物信息分析及功能探讨[J].解剖学报,2019,50(3):310-316.
[8] Liu ZhJ, Dou LT, Zhuang Zh, et al. Screening and survival analysis of differentially expressed genes in papillary thyroid [J]. Acta Anatomica Sinica, 2020, 51(1): 51-57. (in Chinese)
刘中娇, 窦龙涛, 庄振, 等. 乳头状甲状腺癌差异表达基因的筛选及生存分析[J]. 解剖学报, 2020, 51(1): 51-57.
[9] Kiss O, Tkés AM, Vranic S, et al. Expression of miRNAs in adenoid cystic carcinomas of the breast and salivary glands[J]. Virchows Arch, 2015, 467(5): 551-562.
[10] Qiao Z, Zou Y, Zhao H. MicroRNA-140-5p inhibits salivary adenoid cystic carcinoma progression and metastasis via targeting survivin[J]. Cancer Cell Int, 2019, 19(1): 301-312.
[11] Brown AL, Al-Samadi A, Sperandio M, et al. MiR-455-3p, miR-150 and miR-375 are aberrantly expressed in salivary gland adenoid cystic carcinoma and polymorphous adenocarcinoma[J]. J Oral Pathol Med, 2019, 48(9): 840-845.
[12] Li J, Gao H, Meng L, et al. Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma[J]. Tumor Biol, 2017, 39(6): 1010428317708697.
[13] Tian H, Ge C, Li H, et al. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma[J]. Hepatology, 2014, 59(4): 1459-1470.
[14] Wang W, Xiong Y, Ding X, et al. Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC[J]. J Exp Clin Cancer Res, 2019, 38(1): 61.
[15] Wu Y, Shi W, Tang T, et al. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2[J]. Cell Death Dis, 2019, 10(3): 1-16.
[16] Zhong G, Lou W, Yao M, et al. Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer[J]. Epigenomics, 2019, 11(13): 1501-1518.
[17] Ding LC, Huang XY, Zheng FF, et al. FZD2 inhibits the cell growth and migration of salivary adenoid cystic carcinomas[J]. Oncol Rep, 2016, 35(2): 1006-1012.
[18] Xie S, Yu X, Li Y, et al. Upregulation of lncRNA ADAMTS9-AS2 promotes salivary adenoid cystic carcinoma metastasis via PI3K/Akt and MEK/Erk signaling[J]. Mol Ther, 2018, 26(12): 2766-2778.
[19] He Q, Zhou X, Li S, et al. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway[J]. Biochim Biophys Acta, 2013, 1830(11): 5258-5266.
|